Literature DB >> 12846554

Morphological and immunocytochemical characterization of cultured fibroblast-like cells derived from adult human synovial membrane.

F Vandenabeele1, C De Bari, M Moreels, I Lambrichts, F Dell'Accio, P L Lippens, F P Luyten.   

Abstract

The synovial membrane (SM) is a source of multipotent mesenchymal stem cells (MSCs), which appeared microscopically to be a relatively homogeneous population of fibroblast-like cells (FCs) in culture (De Bari et al., 2001). The aim of this study was to investigate phenotypic characteristics of the SM-derived FCs (SD-FCs) that could elucidate their origin inside the synovial tissue. Morphological characterization of SD-FCs was assessed by electron microscopy and by expression of surfactant protein A (SPA). This study, yielded substantial evidence that SD-FCs show ultrastructural and immunocytochemical features of type B synoviocytes; they contained characteristic lamellar bodies (LBs) that are secreted by exocytosis. LB secretion ability was maintained upon passaging (P3-P10). Immunocytochemistry showed that SD-FCs express surfactant protein A (SP-A). Taken together, these results indicate that multipotent SD-MSCs may originate from the synovial lining, having a phenotype highly similar to that of type B synoviocytes. We believe our data highlight the potent ability of type B synoviocytes to have a multilineage differentiation potential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12846554     DOI: 10.1679/aohc.66.145

Source DB:  PubMed          Journal:  Arch Histol Cytol        ISSN: 0914-9465


  23 in total

Review 1.  Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells.

Authors:  Wesley M Jackson; Leon J Nesti; Rocky S Tuan
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

Review 2.  Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells.

Authors:  Wesley M Jackson; Leon J Nesti; Rocky S Tuan
Journal:  Expert Opin Biol Ther       Date:  2010-04       Impact factor: 4.388

Review 3.  Osteochondral tissue engineering approaches for articular cartilage and subchondral bone regeneration.

Authors:  Silvia Panseri; Alessandro Russo; Carla Cunha; Alice Bondi; Alessandro Di Martino; Silvia Patella; Elizaveta Kon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-09-11       Impact factor: 4.342

Review 4.  Cell-based meniscal tissue engineering: a case for synoviocytes.

Authors:  Derek B Fox; Jennifer J Warnock
Journal:  Clin Orthop Relat Res       Date:  2011-10       Impact factor: 4.176

Review 5.  Cell-based articular cartilage repair: the link between development and regeneration.

Authors:  K L Caldwell; J Wang
Journal:  Osteoarthritis Cartilage       Date:  2014-11-11       Impact factor: 6.576

Review 6.  Mesenchymal Stem/Progenitor Cells Derived from Articular Cartilage, Synovial Membrane and Synovial Fluid for Cartilage Regeneration: Current Status and Future Perspectives.

Authors:  Yi-Zhou Huang; Hui-Qi Xie; Antonietta Silini; Ornella Parolini; Yi Zhang; Li Deng; Yong-Can Huang
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

7.  Mesenchymal progenitor cells derived from traumatized human muscle.

Authors:  W M Jackson; A B Aragon; F Djouad; Y Song; S M Koehler; L J Nesti; R S Tuan
Journal:  J Tissue Eng Regen Med       Date:  2009-02       Impact factor: 3.963

8.  Phenotypic characterization and in vivo localization of human adipose-derived mesenchymal stem cells.

Authors:  Young-Joon Ryu; Tae-Jun Cho; Dong-Sup Lee; Jin-Young Choi; Jaejin Cho
Journal:  Mol Cells       Date:  2013-05-14       Impact factor: 5.034

9.  CD14-negative isolation enhances chondrogenesis in synovial fibroblasts.

Authors:  Bahar Bilgen; Yuexin Ren; Ming Pei; Roy K Aaron; Deborah McK Ciombor
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

10.  Primary ciliogenesis defects are associated with human astrocytoma/glioblastoma cells.

Authors:  Joanna J Moser; Marvin J Fritzler; Jerome B Rattner
Journal:  BMC Cancer       Date:  2009-12-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.